Canonical: https://ownershiptrace.com/13f/companies/2501

# Who owns AbCellera Biologics Inc. (ABCL)? Elite investor 13F holders

3 tracked elite investors reported holding AbCellera Biologics Inc as of 2026-06-30, including Tudor Investment, Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | Abcellera Biologics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16196049.00 USD | 2063191.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | Abcellera Biologics Inc | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 7778793.00 USD | 990929.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Abcellera Biologics Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 356633.00 USD | 45431.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)